ArticleForensic science international. Synergy2025
Recommendations for victim survivability assessment methodology based on the Manchester Arena Bombing Inquiry.
Article in Forensic science international. Synergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An expert panel was assembled to report on whether either earlier or different medical treatment could have allowed any of the 22 fatalities of the Manchester Arena Bomb to survive. The aim of this paper is to report on the methodology used by the panel, and to make recommendations for future forensic analyses of explosive events. The panel comprised individuals with a broad range of expertise who received relevant materials from the Inquiry Solicitors. The methodology used was iterative and comprehensive with the panel meeting together at regular points to: sequentially review all the material; conduct detailed analyses on the material; review the outputs of the analyses; reconcile and address any inconsistencies or points of debate; strictly define the following terms: unsurvivable, unlikely to be survivable, and potentially survivable; and report to the Inquiry. A second level of iteration was overlayed on this due to: early reporting being requested by the Solicitors to the Inquiry prior to all information being provided; and the expert panel conclusions being contested by the family of one of the casualties and the medical experts appointed by their legal teams, resulting in further analyses being conducted by the panel. The following detailed analyses were conducted for each fatality: injury scoring; injury visualisation and mapping; forensic three-dimensional post-mortem CT scan analysis; ballistic injury analysis; blood loss analysis; tourniquet use; blast lung injury; and categorisation and survivability. The panel concluded that 21 individuals suffered unsurvivable injuries and one suffered potentially survivable injuries. In order to complete their tasking, the panel found that: no one piece of evidence and expertise on its own was sufficient; post-mortem CT imaging to assess anatomical damage and body worn video to analyse physiological response were key; and lack of detailed information on survivors hindered the panel's work. The clarity of outputs provided by the panel with only the conclusion regarding one of the fatalities being contested highlights the robustness of this panel approach. The following recommendations are made that, in addition to the information that was provided to the panel during this Inquiry, the following information be provided during any future forensic analyses of explosive events: the location of survivors, and uninjured; medical records of the survivors; the three-dimensional plans of the location; structural damage records; and building records and construction technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.